| P50 | author | Mikael Landén | Q37372407 |
| P2093 | author name string | E Pålsson | |
| | E Joas | |
| | H Najar | |
| | M Kardell | |
| P2860 | cites work | Obesity status and sick leave: a systematic review | Q22242401 |
| | Management of antipsychotic-related weight gain | Q24610124 |
| | SSRI Antidepressant Medications: Adverse Effects and Tolerability | Q24682995 |
| | Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study | Q28238082 |
| | Weight gain: side effect of atypical neuroleptics? | Q33707031 |
| | Risperidone-related weight gain: genetic and nongenetic predictors | Q34516784 |
| | A review of the effect of atypical antipsychotics on weight | Q35035150 |
| | The impact of obesity on psychological well-being | Q36252482 |
| | Polytherapy in bipolar disorder | Q36361982 |
| | Metabolic side effects of antipsychotic medication | Q36879594 |
| | General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. | Q37213547 |
| | Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications | Q37491329 |
| | Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden | Q37916681 |
| | Association between obesity status in young adulthood and disability pension | Q40087765 |
| | Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints | Q42211229 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course | Q46182404 |
| | Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders | Q46474943 |
| | Weight gain in depression remitted with antidepressants: pharmacological or recovery effect? | Q47283733 |
| | Comorbidities of overweight and obesity: current evidence and research issues | Q48737114 |
| | Quetiapine treatment in youth is associated with decreased insulin secretion. | Q50654557 |
| | The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients. | Q51489807 |
| | Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| | weight gain | Q3403879 |
| P304 | page(s) | 606-611 | |
| P577 | publication date | 2017-04-13 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic study | |
| P478 | volume | 135 | |